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Abstract
 
CD4
 
 
 
CD25
 
 
 
 regulatory T (T
 
R
 
) cells can inhibit a variety of autoimmune and inflammatory
diseases, but the precise mechanisms by which they suppress immune responses in vivo remain
unresolved. Here, we have used 
 
Helicobacter hepaticus
 
 infection of T cell–reconstituted recombi-
nation-activating gene (RAG)
 
 
 
/
 
 
 
 mice as a model to study the ability of CD4
 
 
 
CD25
 
 
 
 T
 
R
 
 cells
to inhibit bacterially triggered intestinal inflammation. 
 
H. hepaticus
 
 infection elicited both T
cell-mediated and T cell–independent intestinal inflammation, both of which were inhibited
by adoptively transferred CD4
 
 
 
CD25
 
 
 
 T
 
R
 
 cells. T cell–independent pathology was accompa-
nied by activation of the innate immune system that was also inhibited by CD4
 
 
 
CD25
 
 
 
 T
 
R
 
cells. Suppression of innate immune pathology was dependent on T cell–derived interleukin 10
and also on the production of transforming growth factor 
 
 
 
. Thus, CD4
 
 
 
CD25
 
 
 
 T
 
R
 
 cells do
not only suppress adaptive T cell responses, but are also able to control pathology mediated by
innate immune mechanisms.
Key words: regulatory T cells • Helicobacter • immune tolerance • mucosal immunity • IL-10
 
Introduction
 
The key role that the immune system plays in regulating in-
testinal integrity has been demonstrated by the development
of multiple rodent models of mucosal inflammation that are
associated with immunological defects, particularly those
that affect T cells (1). Growing evidence indicates that T
cell responses toward intestinal antigens are normally of a
tolerogenic nature and that dysregulation of mucosal T cell
responses may lead to a loss of tolerance and the develop-
ment of harmful intestinal inflammation similar to that ob-
 
served in human inflammatory bowel disease (IBD)
 
*
 
 (1–3).
A well characterized murine IBD model is the intestinal
inflammation that occurs after adoptive transfusion of na-
ive CD4
 
 
 
CD45RB
 
high
 
 T cells from normal mice into im-
munodeficient recipients (4, 5). The resultant pathology is
due to an excessive Th1-driven inflammatory response in
the intestine and cotransfer of CD4
 
 
 
CD45RB
 
low
 
CD25
 
 
 
 T
cells from normal mice inhibits the colitis (6, 7). Addi-
tional studies in a variety of experimental models of au-
toimmune and inflammatory diseases have confirmed that
regulatory T (T
 
R
 
) cells capable of controlling immune pa-
thology are an integral part of the T cell repertoire in nor-
mal animals (for reviews, see references 8 and 9) and that
their activity is enriched within the minor subpopulation
of CD4
 
 
 
CD45RB
 
low
 
 T cells that express the CD25
marker (10).
Although the precise cellular and molecular pathways in-
volved remain to be defined, current evidence indicates
that T
 
R
 
 cells are able to utilize multiple mechanisms to
suppress immune responses. In vitro studies have demon-
strated that T
 
R
 
 cells can inhibit the activation of other T
cells either directly via a cell contact–dependent mecha-
nism (11–13), or indirectly by down-modulating the activ-
ity of antigen-presenting cells (14, 15). In addition, studies
in animal models have provided strong evidence of a role
for cytokines in the effector function of T
 
R
 
 cells in vivo,
and the inhibition of intestinal inflammation appeared to be
crucially dependent on the presence of the immunosup-
pressive cytokines IL-10 and TGF-
 
 
 
 (7, 16, 17). These
molecules can mediate multiple suppressive effects on both
T cells and on cells of the innate immune system (18, 19).
Although these studies raise the possibility that T
 
R
 
 cells also
inhibit innate immune activation in vivo, the ability of T
 
R
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*
 
Abbreviations used in this paper:
 
 IBD, inflammatory bowel disease; LPL,
 
lamina propria leukocyte; MLN, mesenteric lymph node; T
 
R
 
, regulatory T.T
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Control of Innate Immune Pathology by Regulatory T Cells
 
cells to suppress non-T cell–mediated immune pathology
has not yet been investigated.
The intestinal microflora are essential for the develop-
ment of intestinal inflammation and a number of different
bacterial species have been identified as being able to trig-
ger disease in rodent models of IBD (20–23). One such
organism is 
 
Helicobacter hepaticus
 
, a Gram negative spiral
bacterium that colonizes the intestinal crypts of the cecum
and colon, establishing a life-long infection (24). Al-
though 
 
H. hepaticus
 
 does not usually cause disease in im-
munocompetent mice, infection is associated with hepati-
tis in susceptible inbred strains (25) and it can cause colitis
and typhlitis in immunodeficient mice (26, 27). 
 
H. hepati-
cus
 
 infection has also been shown to exacerbate colitis
in specific pathogen-free (SPF) IL-10
 
 
 
/
 
 
 
 mice and in
RAG
 
 
 
/
 
 
 
 mice reconstituted with naive CD45RB
 
high
 
CD4
 
 
 
 T cells (22, 23). In this study, we have used 
 
H. he-
paticus
 
 infection of immunodeficient RAG
 
 
 
/
 
 
 
 mice as a
model to study the ability of CD4
 
 
 
CD25
 
 
 
 T
 
R
 
 cells to in-
hibit bacterially driven T cell–dependent and T cell–inde-
pendent intestinal inflammation.
 
Materials and Methods
 
Mice.
 
129SvEv, 129SvEvRAG2
 
 
 
/
 
 
 
, and 129SvEvIL-10
 
 
 
/
 
 
 
mice were bred under SPF conditions and maintained in micro-
isolator cages with filtered air in the Pathology Services Building
at the University of Oxford. Mice were routinely screened for
the presence of 
 
Helicobacter spp.
 
 and were 6–10 wk old when
first used.
 
Bacteria. Helicobacter hepaticus
 
 was isolated from infected
129SvEvRAG2
 
 
 
/
 
 
 
 mice as described previously (24), by cultur-
ing cecal scrapings from infected mice on blood agar plates con-
taining trimethoprim, vancomycin and polymixin B (all from
Oxoid) under microaerophilic conditions (CampyPak; Oxoid).
 
H. hepaticus
 
 were characterized morphologically using phase-con-
trast microscopy and were Gram negative, and urease, catalase,
and oxidase positive. Identity was confirmed by PCRs specific for
 
H. hepaticus
 
 16sRNA (27), urease (28), and cytolethal distending
toxin (CDT; reference 29). Cultures were expanded for 3–4 d in
TSB (Oxoid) containing 10% FCS (GIBCO BRL) and 
 
Helico-
bacter
 
-free 129SvEvRAG2
 
 
 
/
 
 
 
 mice were inoculated by oral
gavage of 2 
 
 
 
 10
 
8
 
 cfu 
 
H. hepaticus
 
.
 
Purification of T Cell Subsets.
 
CD4
 
 
 
 T cell subsets were iso-
lated from spleen cells from 
 
Helicobacter
 
-free 129SvEv mice us-
ing magnetic bead based separation techniques and FACS
 
®
 
 sort-
ing, essentially as described previously (7, 30). Briefly, single cell
suspensions were depleted of CD8
 
 
 
, MHC class II
 
 
 
, Mac-1
 
 
 
,
and B220
 
 
 
 cells by negative selection using a panel of rat
mAb,  followed by sheep anti–rat–coated Dynabeads (Dynal).
CD4
 
 
 
CD45RB
 
low
 
CD25
 
 
 
 T cells were purified by staining with
biotinylated-anti-CD25 (BD Biosciences) followed by streptavi-
din-conjugated microbeads (Miltenyi Biotec) and positively se-
lected using AutoMACS (Miltenyi Biotec), according to the
manufacturer’s instructions. CD4
 
 
 
CD45RB
 
high
 
 T cells were
similarly isolated using AutoMACS, following staining with
FITC-anti-CD45RB (BD Biosciences), followed by anti-FITC-
conjugated microbeads (Miltenyi Biotec). Alternatively, after
staining with Cy-Chrome-conjugated anti-CD4, PE-conju-
gated anti-CD25 and FITC-anti-CD45RB (all from BD Bio-
sciences), CD4
 
 
 
 T cell subsets were purified by cell sorting, us-
 
ing a FACSVantage™ (BD Biosciences). Purity of the CD4
 
 
 
 T
cell subsets was assessed using flow cytometry and ranged from
92–99%.
 
T Cell Reconstitution and Antibody Treatments.
 
129SvEv
RAG2
 
 
 
/
 
 
 
 mice were reconstituted by intraperitoneal injec-
tion of 4 
 
 
 
 10
 
5
 
 CD4
 
 
 
CD45RB
 
high
 
 T cells and/or 10
 
5
 
CD4
 
 
 
CD45RB
 
low
 
CD25
 
 
 
 T cells and infected with 
 
H. hepaticus
 
24 h later. Antibody treatments were commenced the day after T
cell reconstitution. Where indicated, mice were treated with 1
mg/wk anti–IL-12p40 (C17.8.20) for the first 2 wk after infection,
or weekly throughout the duration of the experiment with 2 mg
anti-TNF-
 
 
 
 (XT22), 2 mg anti-TGF-
 
 
 
 (1D11), or 0.5 mg anti-
IL10R (1B1.2) or isotype control by intraperitoneal injection.
 
Assessment of Intestinal Inflammation.
 
Mice were killed 8–12
wk after 
 
H. hepaticus
 
 infection and samples of cecum, proximal,
mid, and distal colon were isolated and fixed in buffered 10% for-
malin. 5 
 
 
 
m paraffin-embedded sections were cut and stained
with hematoxylin and eosin. Inflammation was assessed as previ-
ously described (7, 17), each sample was graded semiquantita-
tively from 0–4 and typical features of each grade are: 0 
 
 
 
 nor-
mal; 1 
 
 
 
 mild epithelial hyperplasia; 2 
 
 
 
 pronounced hyperplasia
and significant inflammatory infiltrates; 3 
 
 
 
 severe hyperplasia
and infiltration with significant decrease in goblet cells; 4 
 
 
 
 se-
vere hyperplasia, severe transmural inflammation, ulceration,
crypt abscesses, and substantial depletion of goblet cells. Ceca and
colons were assessed separately and at least three separate sections
from each sample were scored blind.
 
Flow Cytometry.
 
Aliquots of 1–5 
 
 
 
 10
 
5
 
 cells were stained in
FACS
 
®
 
 buffer (PBS, 0.1% BSA, 5 mM EDTA; both from Sigma-
Aldrich) using the following panel of mAb to murine cell surface
molecules (all from BD Biosciences); biotinylated anti-NK cells
(DX5), biotinylated anti-Gr1 (Ly6G), allophycocyanin (APC)-
conjugated anti-CD11b, PE-anti-CD11c, peridinine chlorophyll
protein (PerCP)-conjugated anti-CD4, FITC-conjugated anti-
class II MHC, PE-anti–mouse TCR
 
 
 
. Biotinylated antibodies
were detected using PE-, APC-, or FITC-conjugated streptavi-
din (SA; all from BD Biosciences). Staining steps were performed
for 30 min on ice and, after washing with FACS
 
®
 
 buffer, samples
were fixed in FACS® buffer containing 2% paraformaldehyde
(BDH) and analyzed using a FACSCalibur™ with CELLQuest™
software (Becton Dickinson). For intracellular cytokine analysis,
spleen cells (2.5   106 cells/ml) were incubated in complete
RPMI 1640 (10% heat-inactivated FCS, 2 mM l-glutamine, 100
U/ml penicillin and streptomycin [GIBCO BRL], and 0.05 mM
2-mercaptoethanol [Sigma-Aldrich]) supplemented with 1,000
U/ml rhIL-2 (Sigma), for 18 h at 37 C in a humidified incubator
with 5% CO2. Brefeldin A (BFA, 10 mg/ml; Sigma-Aldrich) was
added for the final 4 h of incubation. Cell surface staining was
performed as described above and after fixing, the samples were
incubated in permeabilization (Perm) buffer (PBS, 0.1% BSA,
0.5% saponin; Sigma-Aldrich) containing PE-anti–mouse IFN- 
or isotype control (BD Biosciences) for 30 min at room tempera-
ture, washed in Perm buffer, and analyzed as above.
Isolation of Lamina Propria Leukocytes. Lamina propria leuko-
cytes (LPLs) were purified from ceca as described (6). Briefly,
ceca were pooled from 4–6 mice per group, contents were re-
moved, and ceca were rinsed in PBS. Ceca were cut into 0.3–
0.5-cm pieces and repeatedly incubated in Ca- and Mg-free PBS
containing 10% FCS and 5 mM EDTA to release intestinal epi-
thelial cells. The remaining tissue was further digested with colla-
genase/dispase (100 U/ml; Sigma-Aldrich) and the LPL were
then layered on a discontinuous Percoll gradient (Amersham Bio-
sciences). After centrifugation at 600 g for 20 min, the LPL popu-T
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113 Maloy et al.
lation was recovered at the 40/75% interface, washed twice in
PBS/BSA, and analyzed using flow cytometry as detailed above.
Quantitation of H. hepaticus Using Real-time PCR. DNA was
purified from cecal or fecal scrapings taken from H. hepaticus–
infected mice using the DNA Stool kit (QIAGEN). H. hepaticus
DNA was quantified as described (29) using a real-time PCR
method based on the cdtB gene, performed with the ABI prism
Taqman 7700 sequence detection system (PE Biosystems). Stan-
dard curves were constructed using H. hepaticus DNA that was
purified from bacterial cultures using the DNeasy kit (QIAGEN).
Statistics. The nonparametric Mann-Whitney test was used
for comparing pathology scores and cell counts and differences
were considered statistically significant when P   0.05.
Results
CD4 CD25  TR Cells Protect Against both T Cell–depen-
dent and T Cell–independent Intestinal Inflammation Triggered
by Infection with H. hepaticus. To examine whether TR
cells could prevent intestinal inflammation induced by
the bacterial pathogen H. hepaticus, we isolated CD4 
CD45RBlowCD25  T cells and CD4 CD45RBlow
CD25  T cells from normal mice and coinjected these
subpopulations with CD4 CD45RBhigh T cells into
129SvEvRAG2 /  recipients that were then infected
with H. hepaticus. Although CD4 CD45RBhigh T cell re-
constitution of RAG2 /  mice induced only minimal
changes in intestinal architecture (Figs. 1 and 2 D), con-
comitant infection of these mice with H. hepaticus led to
the development of severe intestinal inflammation, char-
acterized by marked epithelial cell hyperplasia, extensive
inflammatory infiltrates, and goblet cell depletion (Figs.
1 and 2 E). While cotransfer of CD4 CD45RBlowCD25 
T cells completely inhibited the development of disease,
CD4 CD45RBlowCD25  T cells were unable to prevent
H. hepaticus–triggered intestinal inflammation (Figs. 1 and
2, F and G).
H. hepaticus infection of RAG2 /  mice led to the de-
velopment of significant intestinal inflammation, even in
the absence of T cell reconstitution (Figs. 1 and 2 B). This
T cell–independent pathology was generally less severe
than the T cell–mediated disease, again involving marked
epithelial cell hyperplasia, but with little depletion of mu-
cin-producing cells (compare Fig. 2, B and E). Inflamma-
tory infiltrates comprised of both polymorphonuclear cells
and mononuclear cells were also present, although mark-
edly less dense than those present in the T cell-mediated
form of disease (compare Fig. 2, B and E). Consistent with
previous reports of H. hepaticus–induced intestinal disease
(23, 27), the most severe T cell–independent inflammation
was observed in the cecum (Figs. 1 and 2 I). Impor-
tantly,  reconstitution of RAG2 /  mice with CD4 
Figure 1. CD4 CD25  T cells prevent both T cell–dependent and T
cell–independent intestinal inflammation. 129SvEvRAG2 /  mice were
reconstituted with purified CD4  T cell subsets as indicated (4   105
CD45RBhigh T cells and/or 105 CD4 CD45RBlowCD25  T cells or
CD4 CD45RBlowCD25  T cells) and infected 24 h later by oral gavage
with 2   108 cfu H. hepaticus. Mice were killed 8–12 wk later and pathol-
ogy in the colon (A) and cecum (B) was assessed histologically. Each sym-
bol represents a single animal and results are representative of two similar
experiments. **P   0.01 vs. RBhi   Hh; *P   0.05 vs. Hh.
Figure 2. Representative photomicrographs of hematoxylin and eosin
stained intestinal tissues from 129SvEvRAG2 /  mice that were reconsti-
tuted with purified CD4  T cell subsets and/or infected with H. hepaticus
as outlined in Fig. 1. (A–G) Colon sections from a control RAG2 / 
mouse (A) and from mice that received; H. hepaticus only (B), H. hepat-
icus and CD4 CD45RBlowCD25  T cells (C), CD4 CD45RBhigh T
cells only (D), CD4 CD45RBhigh T cells and H. hepaticus (E),
CD45RBhighCD4  T cells plus CD4 CD45RBlowCD25  T cells and H.
hepaticus (F), or CD45RBhighCD4  T cells plus CD4 CD45RBlowCD25 
T cells and H. hepaticus (G). (H–J) Cecum sections from a control
RAG2 /  mouse (H) and from mice that received; H. hepaticus only (I),
or H. hepaticus and CD4 CD45RBlowCD25  T cells (J). Original magni-
fication:  50.T
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114 Control of Innate Immune Pathology by Regulatory T Cells
CD45RBlowCD25  T cells also inhibited the development
of H. hepaticus–induced T cell–independent intestinal in-
flammation in both the cecum and colon (Figs. 1 and 2, C
and J). Conversely, reconstitution with CD4 CD45RBlow
CD25  T cells did not prevent H. hepaticus–triggered T
cell–independent intestinal pathology (unpublished data).
Together, these results demonstrate that H. hepaticus is able
to induce significant intestinal inflammation in RAG2 / 
mice, that this inflammation is exacerbated when the
RAG2 /  mice are reconstituted with CD4 CD45RBhigh
T cells and, most importantly, that both the T cell–depen-
dent and T cell–independent forms of disease are inhibited
by CD4 CD45RBlowCD25  TR cells.
T Cell–independent Immune Pathology Triggered by Infection
with H. hepaticus Is Driven by Proinflammatory Cytokines and
Is Associated with Local and Systemic Activation of Innate Immu-
nity that Is Inhibited by CD4 CD25  TR Cells. To examine
the role of proinflammatory cytokines in the T cell–inde-
pendent intestinal inflammation we treated H. hepaticus–
infected RAG2 /  mice with monoclonal antibodies to IL-
12p40 or TNF- , from the onset of infection. As shown in
Fig. 3, treatment with anti–IL-12p40 or anti–TNF-  sig-
nificantly inhibited the development of intestinal inflamma-
tion, suggesting that the intestinal pathology was driven by
the activation of host innate immune responses.
In addition to the marked intestinal changes, we also ob-
served significant splenomegaly in RAG2 /  mice that
were infected with H. hepaticus (Fig. 4 A). Flow cyto-
metric analyses (31) revealed that this was primarily due
to substantial increases in the numbers of neutrophils
(Gr1highCD11bhigh, 10 to 20-fold; Fig. 4 B) and mono-
cytes/macrophages (Gr1lowCD11bhigh, 5 to 10-fold; Fig. 4
C) present in the spleens of H. hepaticus–infected RAG2 / 
mice, with only modest increases in the number of den-
dritic cells (CD11chighMHC IIhigh, twofold; Fig. 4 D). Al-
though there were only similarly modest increases in the
total number of NK cells (twofold; Fig. 4 E), there was also
a twofold increase in the proportion of NK cells producing
IFN-  (control 5.6   1.3%; Hh 10.4   2.8%; Hh   
CD25 T 4.1   1.9%), which together resulted in sub-
stantial increases in the number of IFN-   NK cells
(fourfold; Fig. 4 F), confirming that H. hepaticus infection
led to extensive activation of innate immune cells in
RAG2 /  mice. Importantly, adoptive transfer of CD4 
CD45RBlowCD25  T R cells significantly reduced sple-
nomegaly, granulocyte and monocyte recruitment and NK
cell activation observed in RAG2 /  mice after H. hepati-
cus infection (Fig. 4).
To assess innate immune activation at the site of infec-
tion, we isolated leukocyte populations from the lamina
propria of the cecum (LPL) and from the mesenteric lymph
node (MLN) and characterized their composition using
flow cytometry. Due to the small numbers of leukocytes
present in these tissues, we analyzed pooled LPL or MLN
populations from the different groups of mice (Table I). H.
hepaticus infection of RAG /  mice elicited a marked in-
crease in the number of LPL isolated from cecal tissue
(eightfold, Table I). Strikingly, although they were not
present in LPL populations isolated from control RAG / 
mice, neutrophils constituted almost 20% of LPL isolated
from inflamed ceca in H. hepaticus–infected RAG /  mice
(Table I). By contrast, no marked differences in the relative
proportions of monocytes or NK cells were observed in
LPL populations isolated from control or H. hepaticus–
infected RAG /  mice (Table I). Importantly, reconstitution
of H. hepaticus–infected RAG /  mice with CD4 CD25 
TR cells prevented the accumulation of neutrophils in the
cecal lamina propria and reduced LPL numbers to those
found in control RAG mice (Table I). Interestingly, CD4 
Figure 3. H. hepaticus–triggered T cell–
independent intestinal inflammation is
driven by proinflammatory cytokines.
129SvEvRAG2 /  mice were infected by
oral gavage with 2   108 cfu H. hepaticus.
Where indicated, mice received 1 mg/wk
anti–IL-12p40 for the first 2 wk after infec-
tion or 2 mg/wk anti-TNF-  throughout
the course of the infection. Mice were
killed 8–12 wk later and pathology in the
cecum was assessed histologically. Each
symbol represents a single animal and results
are representative of two similar experi-
ments.  **P     0.01 vs. anti–IL-12p40 or
anti-TNF- .
Figure 4. H. hepaticus infection of RAG2 /  mice induces systemic
activation of innate immunity that is inhibited by CD4 CD25  T
cells.  129SvEvRAG2 /  mice were reconstituted with 105 CD4 
CD45RBlowCD25  T cells and/or infected by oral gavage with 2   108
cfu H. hepaticus. Mice were killed 8–12 wk later and spleen cell popula-
tions were enumerated using FACS® analyses. Graphs shown represent
numbers of total spleen cells (A), neutrophils (B), monocytes/macro-
phages (C), dendritic cells (D), NK cells (E), and IFN- –producing NK
cells (F). Each symbol represents a single animal and results are representa-
tive of two similar experiments. **P   0.01 vs. Hh; *P   0.05 vs. Hh.T
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115 Maloy et al.
T cells accounted for around 15% of the LPL isolated from
H. hepaticus–infected RAG /  mice that had received
CD4 CD25  TR cells (Table I). Although H. hepaticus in-
fection also slightly increased the number of MLN cells
when compared with control RAG /  mice (2–3-fold),
this was primarily due to an increased proportion of mono-
cytes, with no significant increase in the proportion of neu-
trophils and a marked decrease in the proportion of NK
cells (Table I). However, in contrast to the spleen and LPL
populations, fivefold higher numbers of MLN cells were
present in H. hepaticus–infected RAG /  mice that had re-
ceived CD4 CD25  TR cells, and this was primarily due
to the high proportion (22%) of CD4  T cells found in the
MLN populations isolated from these mice (Table I).
Together, the results described above indicate that
CD4 CD25  TR cells do not mediate their effects only on
other T cells, but are also able to control chronic immune
pathology mediated by sustained activation of innate im-
mune mechanisms. In addition, they show that CD4 
CD25  TR cells efficiently reconstitute both mucosal and
systemic lymphoid compartments, suggesting that they may
act at multiple sites to inhibit harmful immune pathology
caused by the accumulation and activation of innate im-
mune cells.
CD4 CD25  TR Cells Do Not Influence H. hepaticus Col-
onization Levels. To assess whether CD4 CD25  T R
cells might have inhibited intestinal pathology by mediat-
ing protective immunity against H. hepaticus, we used a
real time PCR assay (29) to quantitate H. hepaticus levels in
cecum and colon scrapings from infected RAG2 /  mice,
in the presence or absence of CD4 CD25  TR cells. In
infected RAG2 /  mice we detected the highest levels of
H. hepaticus in the cecum, with 5 to 10-fold lower levels
present in the colon (Fig. 5). Crucially, reconstitution of
RAG2 /  mice with CD4 CD25  TR cells had no mea-
surable effect on the levels of H. hepaticus DNA detected
in the cecum or colon (Fig. 5), indicating that the protec-
tion from H. hepaticus–triggered intestinal inflammation
was not due to eradication of the bacteria or decreased lev-
els of colonization.
CD4 CD25  TR Cell–mediated Protection against T Cell-
independent Intestinal Inflammation Is Cytokine Dependent.
Previous studies have highlighted the important roles of IL-
10 and TGF-  in the regulation of intestinal inflammation
(7, 16, 17, 32). In addition, H. hepaticus has also been
shown to be able to trigger severe intestinal inflammation
in IL-10 /  mice (23, 33). We therefore examined
whether these cytokines also played a role in the inhibition
of T cell–independent intestinal inflammation induced by
H. hepaticus. Thus, RAG2 /  mice were reconstituted with
CD4 CD25  T R cells, infected with H. hepaticus and
treated throughout the course of infection with mono-
clonal antibodies reactive with IL-10R or TGF- . As
shown in Fig. 6, treatment with anti–IL-10R or anti–
TGF-  completely ablated the ability of CD4 CD25  TR
cells to inhibit H. hepaticus–induced intestinal inflamma-
tion. Furthermore, we also observed that CD4 CD25  T
cells from IL-10 /  mice were unable to inhibit H. hepati-
cus–induced intestinal inflammation (Fig. 6), suggesting that
T cell–derived IL-10 plays a crucial role in the control of
innate immune pathology by CD4 CD25  TR cells. The
inability to protect from T cell–independent intestinal in-
flammation was not due to ineffective T cell reconstitution,
as approximately twofold more CD4 T cells were re-
covered from RAG2 /  mice that received IL-10 / 
CD4 CD25  T cells or anti–IL-10R or anti–TGF-  treat-
ment, when compared with those that received wild-type
CD4 CD25  T cells only (unpublished data).
Discussion
Although the role of T cells in the induction of intestinal
inflammation has received much attention, these results
emphasize that innate immune mechanisms are also able to
Table I. Composition of Mucosal Lymphoid Populations in
H. hepaticus–infected RAG /  Mice
Tissue Group Cell no.  Neuts Monos DC NK
CD4 
T
%% % % %
LPL Control 2.8   104 0.6 18.2 8.8 3.0 0.3
Hh 2.1   105 17.5 13.0 6.0 8.1 0.3
Hh   25  2.5   104 0.4 14.6 7.3 5.8 15.2
MLN Control 1.4   105 1.8 15.1 4.5 47.7 0.2
Hh 3.6   105 4.0 31.7 4.7 25.2 0.3
Hh   25  7.7   105 0.5 10.2 5.6 15.8 22.1
Groups of 129SvEvRAG2 /  mice were left untreated (Control), or
infected by oral gavage with 2   108 cfu H. hepaticus (Hh), or infected
with  H. hepaticus and reconstituted with 1   105 CD4 
CD45RBlowCD25  T cells (Hh   25 ). Mice were sacrificed 8–12 wk
later and LPL and MLN populations (pooled from 4–6 mice per group)
were characterized using FACS® analyses. Mean cell number for each
tissue was calculated by dividing the total number of cells isolated by the
number of mice pooled. Results shown are representative of two similar
experiments.
Figure 5. CD4 CD25  T
cell reconstitution does not af-
fect  H. hepaticus colonization
levels in RAG2 /  mice.
129SvEvRAG2 /  mice were
reconstituted with 105 CD4 
CD45RBlowCD25  T cells and/
or infected by oral gavage with
2   108 cfu H. hepaticus. Mice
were killed 10 wk later, DNA
was isolated from cecum and co-
lon samples and H. hepaticus
DNA was quantified using a
real-time PCR assay. Each sym-
bol represents a single animal and
results are representative of two
similar experiments.T
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mediate significant intestinal inflammation upon stimula-
tion with pathogenic organisms like H. hepaticus (26, 27,
34, 35). In addition, we show here that T cell–independent
intestinal inflammation triggered by H. hepaticus infection
of RAG2 /  mice was driven by proinflammatory cyto-
kines, was accompanied by local and systemic innate im-
mune activation and was completely inhibited by cotransfer
of CD4 CD25  T R cells through cytokine-dependent
mechanisms. These results represent the first clear evidence
showing that the immune suppressive properties of
CD4 CD25  TR cells are not limited to effects on other T
cell responses, but also include inhibition of immune pa-
thology mediated by cells of the innate immune system.
The mechanisms by which TR cells mediate their sup-
pressive functions are the subject of intensive debate. Dif-
ferent in vivo models of disease suppression show different
patterns of dependency on various immune suppressive cy-
tokines and there is good evidence that a cell contact–
dependent mechanism is involved in the suppression of T
cell responses in vitro (for reviews, see references 8 and 36). An
alternative explanation that has been proposed for TR cell
phenomena is that regulatory activity is not the sole prop-
erty of a defined T cell subpopulation, but rather can be ac-
complished by any kind of T cell that is able to compete for
‘space’ and survival factors with potentially pathogenic T
cells (37). However, suppression of H. hepaticus–triggered
innate immune pathology was a unique property of
CD4 CD25  T R cells. In addition, our results illustrate
that CD4 CD25  T R cells do not exclusively mediate
their suppressive functions by inhibiting other T cell re-
sponses. Since in many inflammatory and autoimmune dis-
eases pathology is associated with the activation and accu-
mulation of innate immune effector cells, the inhibition of
such responses by TR cells extends the therapeutic potential
of manipulations of TR cell function. Nevertheless, it is im-
portant to emphasize the delicate balance that TR cells must
maintain between allowing protective immune responses
to proceed efficiently, while inhibiting harmful immune
pathology. This raises the possibility that excessive TR cell
activity may actually impede protective immunity. One
such instance was recently reported in scid mice infected
with Pneumocystis carinii, where the elimination of P. carinii
mediated by adoptively transferred CD4 CD25  T cells
was suppressed when CD4 CD25  T cells were cotrans-
ferred (38).
The suppression of T cell–independent immune pathol-
ogy by CD4 CD25  TR cells was dependent on the ac-
tions of IL-10 and TGF- , as treatment with anti–IL-10R
or anti–TGF-  completely abrogated protection against H.
hepaticus–induced intestinal inflammation. This observa-
tion further confirms the central role of these immunosup-
pressive cytokines in preventing intestinal inflammation,
highlighted by their key role in the suppression of T cell–
mediated colitis by CD4 CD45RBlow T cells (6, 16, 17)
and by the development of colitis in IL-10 /  mice (32).
Our findings are also consistent with a previous study
showing that the development of T cell–independent intes-
tinal inflammation in RAG2 /  mice exposed to a flora
that included H. hepaticus could be inhibited by treatment
with rIL-10 (39). Importantly, our results suggest a cru-
cial  role for T cell–derived IL-10 in this process, as
CD4 CD25  T cells from IL-10 /  mice were unable to
inhibit the development of intestinal inflammation. There
is clear evidence that IL-10 has inhibitory effects on cells of
the innate immune system, including the suppression of
pro-inflammatory cytokine and chemokine production by
activated monocytes/macrophages and neutrophils (for a
review, see reference 19). An excellent example highlight-
ing the importance of the actions of IL-10 in controlling
innate immune cells in the intestine is the observation that
transgenic mice with a cell-type deletion in Stat-3, in
which macrophages and neutrophils are unresponsive to
IL-10, spontaneously develop intestinal inflammation (40).
We observed that H. hepaticus infection of 129SvEv
RAG2 /  mice triggered intestinal inflammation that was
characterized by epithelial cell hyperplasia and by marked
infiltration of both granulocytic and mononuclear cells.
Immune pathology was most prominent in the cecum,
where the highest colonization by H. hepaticus occurred.
The immune pathology found in H. hepaticus-infected
RAG2 /  mice was driven by proinflammatory cytokines,
as it was significantly inhibited by treatment with anti–IL-
12p40 or anti–TNF-  antibodies. In addition, Helicobacter-
triggered intestinal inflammation is associated with in-
creased production of proinflammatory molecules, such as
IL-1, TNF- , iNOS, and IFN-  (33, 35). The induction
of innate immune pathology in the gastrointestinal tract
has also been observed in immunodeficient mice infected
with other bacteria, including Campylobacter fetus (41) and
Citrobacter rodentium (42), suggesting that potentially
pathogenic innate immune responses may occur com-
monly in the intestine after colonization with pathogenic
organisms.
The present study demonstrates that the development of
T cell–mediated colitis in 129SvEvRAG2 /  mice requires
H. hepaticus infection, whereas we have previously found
that adoptive transfer of naive syngeneic CD4  T cells into
Figure 6. CD4 CD25  T
cell–mediated protection against
T cell–independent intestinal in-
flammation is dependent on IL-10
and TGF- . 129SvEvRAG2 / 
mice were reconstituted with
105 CD4 CD45RBlowCD25  T
cells from wild-type or IL-10 / 
mice and/or infected by oral
gavage with 2   108 cfu H. he-
paticus. Where indicated mice re-
ceived 0.5 mg/wk anti–IL-10R
or 2 mg/wk anti-TGF- . Mice
were killed 8–12 wk later, ceca
samples were taken for histologi-
cal examination. Each symbol
represents a single animal and re-
sults are representative of two
similar experiments. **P   0.01
vs. Hh.T
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CB17 scid or C57BL/6 RAG /  mice leads to severe coli-
tis, even in the absence of H. hepaticus (7). While the rea-
sons for these differences are not yet clear, they highlight
the fact that the incidence and severity of colitis observed
in immune deficient mice after T cell adoptive transfer will
be heavily dependent on both environmental factors, espe-
cially the intestinal micro-flora, as well as genetic factors,
such as mouse strain differences. Similarly, different im-
mune deficient strains in our animal facilities exhibit differ-
ent susceptibilities to T cell–independent intestinal inflam-
mation induced by H. hepaticus infection, with C57BL6
RAG /  mice and CB17 scid mice exhibiting minimal in-
testinal inflammation after infection with H. hepaticus (un-
published data). In our opinion, similar host environmental
and genetic influences, in combination with bacterial strain
differences, may account for the wide range of susceptibili-
ties, kinetics, and severity of disease observed in different
immunodeficient mouse strains upon infection with H. he-
paticus (26, 27, 34, 35, 43).
The inflammatory changes found in H. hepaticus–infected
129SvEvRAG2 /  mice were not limited to the intestine,
they were accompanied by systemic innate immune activa-
tion as evidenced by pronounced splenomegaly that was as-
sociated with accumulation of neutrophils and monocytes
and by the enhanced activation of NK cells. Importantly,
we found that adoptively transferred CD4 CD25  TR cells
efficiently reconstituted both systemic and mucosal lym-
phoid compartments, including the lamina propria of the
large intestine and the mesenteric lymph nodes. Reconsti-
tution with CD4 CD25  T R cells completely inhibited
the accumulation and activation of innate immune cells ob-
served in H. hepaticus–infected RAG /  mice, both in the
intestinal lamina propria and also in the spleen. Our results
show that, in addition to inhibiting innate immune pa-
thology in the intestine, CD4 CD25  T R cells can also
suppress the activation and accumulation of innate im-
mune cells in systemic lymphoid tissues, suggesting that
CD4 CD25  TR cells may operate both locally at the in-
flammatory site and systemically to prevent immune pa-
thology.
It is not yet clear whether CD4 CD25  TR cells recog-
nize self-peptides, peptides derived from foreign antigens
or both. In this study we isolated CD4 CD25  T R cells
from normal 129SvEv mice that were free from Helicobacter
infection and demonstrated that they could inhibit intesti-
nal inflammation triggered by H. hepaticus. These results are
consistent with the finding that CD4 CD25  TR cells iso-
lated from germ-free mice were able to inhibit intestinal
pathology mediated by CD4 CD45RBhigh T cells (44),
confirming that TR cells can suppress harmful immune pa-
thology triggered by organisms to which they have not
been previously exposed. The nature of CD4  T cell re-
sponses directed against H. hepaticus has been examined by
Kullberg and colleagues in the IL-10 /  murine model of
IBD (23, 33). H. hepaticus–infected IL-10 /  mice devel-
oped severe colitis that was characterized by the presence of
H. hepaticus-specific CD4  Th1 cell responses in the MLN,
while H. hepaticus infected wild-type mice did not develop
intestinal pathology and mounted an IL-10 dominated re-
sponse (23, 33). Recently, Kullberg et al. have extended
these findings using H. hepaticus infection of naive T cell-
reconstituted C57BL10 RAG /  mice as a model of bacte-
rially driven T cell–mediated colitis (43). This study found
that both CD25  and CD25 CD4 CD45RBlow T cell
populations from wild-type C57BL10 mice could inhibit
the development of colitis, but only when these cells were
purified from H. hepaticus-infected donors (43). Protection
from colitis was associated with IL-10 production by the
CD4 CD45RBlow T cells, but was not dependent on
TGF- . These results suggest H. hepaticus infection of nor-
mal immune competent mice induces CD4  TR cells that
prevent bacterially induced colitis. While it is difficult to
reconcile the discrepancies between these findings and our
own observations, we believe that a number of factors may
contribute. First, as noted above, both genetic strain differ-
ences and environmental factors influence susceptibility to
H. hepaticus–induced intestinal inflammation and it is possi-
ble that different H. hepaticus isolates may also exhibit dif-
fering pathogenic potentials. Second, the intestinal inflam-
mation triggered by H. hepaticus in T cell–reconstituted
C57BL10 RAG /  mice is clearly more severe than the T
cell–independent pathology we observed in 129SvEv
RAG /  mice, therefore it is not surprising that the inhibi-
tion of T cell–mediated colitis may well require higher
numbers of bacteria-specific TR cells. Lastly, as CD25 
CD4  T cell populations have been shown to possess TR
cell activity in other experimental models (45–47) and be-
cause expression of CD25 by TR cells is highly dynamic in
vivo (48), it is not entirely surprising that H. hepaticus infec-
tion of normal immune competent mice may give rise to a
heterogenous population of CD45RBlowCD4  TR cells ca-
pable of inhibiting H. hepaticus–driven intestinal inflamma-
tion. Further studies will be required to more clearly define
the roles of H. hepaticus–specific TR cells, and of TR cells
recognizing self-antigens or other components of the intes-
tinal flora, in the regulation of pathological innate and
adaptive immune responses triggered after infection with
H. hepaticus.
We would like to thank Liz Darley for performing the histology,
Nigel Rust for assistance with the FACS® sorting, staff at the PSB
for animal care and O. Annacker, L. Stephens, and H. Uhlig for
critical review of the manuscript.
This project was supported by a Wellcome Trust Project grant
(F. Powrie) and by Wellcome Trust Fellowships (F. Powrie and
N.J. Saunders).
Submitted: 5 August 2002
Revised: 14 November 2002
Accepted: 19 November 2002
References
1. Strober, W., I.J. Fuss, and R.S. Blumberg. 2002. The immu-
nology of mucosal models of inflammation. Annu. Rev. Im-
munol. 20:495–549.
2. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe,T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
118 Control of Innate Immune Pathology by Regulatory T Cells
and K.H. Meyer zum Buschenfelde. 1995. Tolerance exists
towards resident intestinal flora but is broken in active in-
flammatory bowel disease (IBD). Clin. Exp. Immunol. 102:
448–455.
3. Khoo, U.Y., I.E. Proctor, and A.J. Macpherson. 1997. CD4 
T cell down-regulation in human intestinal mucosa: evidence
for intestinal tolerance to luminal bacterial antigens. J. Immu-
nol. 158:3626–3634.
4. Powrie, F., M.W. Leach, S. Mauze, L.B. Caddle, and R.L.
Coffman. 1993. Phenotypically distinct subsets of CD4  T
cells induce or protect from chronic intestinal inflammation
in C. B-17 scid mice. Int. Immunol. 5:1461–1471.
5. Morrissey, P.J., K. Charrier, S. Braddy, D. Liggitt, and J.D.
Watson. 1993. CD4  T cells that express high levels of
CD45RB induce wasting disease when transferred into con-
genic severe combined immunodeficient mice. Disease de-
velopment is prevented by cotransfer of purified CD4  T
cells. J. Exp. Med. 178:237–244.
6. Powrie, F., M.W. Leach, S. Mauze, S. Menon, L.B. Caddle,
and R.L. Coffman. 1994. Inhibition of Th1 responses pre-
vents inflammatory bowel disease in scid mice reconstituted
with CD45RBhi CD4  T cells. Immunity. 1:553–562.
7. Read, S., V. Malmstrom, and F. Powrie. 2000. Cytotoxic T
lymphocyte-associated antigen 4 plays an essential role in the
function of CD25 CD4  regulatory cells that control intesti-
nal inflammation. J. Exp. Med. 192:295–302.
8. Maloy, K.J., and F. Powrie. 2001. Regulatory T cells in the
control of immune pathology. Nat. Immunol. 2:816–822.
9. Shevach, E.M. 2000. Regulatory T cells in autoimmmunity.
Annu. Rev. Immunol. 18:423–449.
10. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M.
Toda. 1995. Immunologic self-tolerance maintained by acti-
vated T cells expressing IL-2 receptor alpha-chains (CD25).
Breakdown of a single mechanism of self-tolerance causes
various autoimmune diseases. J. Immunol. 155:1151–1164.
11. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M.
Itoh, M. Iwata, J. Shimizu, and S. Sakaguchi. 1998. Immu-
nologic self-tolerance maintained by CD25 CD4  naturally
anergic and suppressive T cells: induction of autoimmune
disease by breaking their anergic/suppressive state. Int. Immu-
nol. 10:1969–1980.
12. Thornton, A.E., and E.M. Shevach. 1998. CD4 CD25  im-
munoregulatory T cells suppress polyclonal T cell activation
in vitro by inhibiting interleukin 2 production. J. Exp. Med.
188:287–296.
13. Thornton, A.M., and E.M. Shevach. 2000. Suppressor effec-
tor function of CD4 CD25  immunoregulatory T cells is
antigen nonspecific. J. Immunol. 164:183–190.
14. Cederbom, L., H. Hall, and F. Ivars. 2000. CD4 CD25 
regulatory T cells down-regulate co-stimulatory molecules
on antigen-presenting cells. Eur. J. Immunol. 30:1538–1543.
15. Vendetti, S., J.G. Chai, J. Dyson, E. Simpson, G. Lombardi,
and R. Lechler. 2000. Anergic T cells inhibit the antigen-
presenting function of dendritic cells. J. Immunol. 165:1175–
1181.
16. Powrie, F., J. Carlino, M.W. Leach, S. Mauze, and R.L.
Coffman. 1996. A critical role for transforming growth fac-
tor-beta but not interleukin 4 in the suppression of T helper
type 1–mediated colitis by CD45RB(low) CD4  T cells. J.
Exp. Med. 183:2669–2674.
17. Asseman, C., S. Mauze, M.W. Leach, R.L. Coffman, and F.
Powrie. 1999. An essential role for interleukin 10 in the
function of regulatory T cells that inhibit intestinal inflamma-
tion. J. Exp. Med. 190:995–1004.
18. Letterio, J.J., and A.B. Roberts. 1998. Regulation of immune
responses by TGF-beta. Annu. Rev. Immunol. 16:137–161.
19. Moore, K.W., R. de Waal Malefyt, R.L. Coffman, and A.
O’Garra. 2001. Interleukin-10 and the interleukin-10 recep-
tor. Annu. Rev. Immunol. 19:683–765.
20. Rath, H.C., H.H. Herfarth, J.S. Ikeda, W.B. Grenther, T.E.
Hamm, Jr., E. Balish, J.D. Taurog, R.E. Hammer, K.H.
Wilson, and R.B. Sartor. 1996. Normal luminal bacteria, es-
pecially Bacteroides species, mediate chronic colitis, gastritis,
and arthritis in HLA-B27/human beta2 microglobulin trans-
genic rats. J. Clin. Invest. 98:945–953.
21. Sellon, R.K., S. Tonkonogy, M. Schultz, L.A. Dieleman, W.
Grenther, E. Balish, D.M. Rennick, and R.B. Sartor. 1998.
Resident enteric bacteria are necessary for development of
spontaneous colitis and immune system activation in inter-
leukin-10-deficient mice. Infect. Immun. 66:5224–5231.
22. Cahill, R.J., C.J. Foltz, J.G. Fox, C.A. Dangler, F. Powrie,
and D.B. Schauer. 1997. Inflammatory bowel disease: an im-
munity-mediated condition triggered by bacterial infection
with Helicobacter hepaticus. Infect. Immun. 65:3126–3131.
23. Kullberg, M.C., J.M. Ward, P.L. Gorelick, P. Caspar, S.
Hieny, A. Cheever, D. Jankovic, and A. Sher. 1998. Helico-
bacter hepaticus triggers colitis in specific-pathogen-free in-
terleukin-10 (IL-10)-deficient mice through an IL-12- and
gamma interferon-dependent mechanism. Infect. Immun. 66:
5157–5166.
24. Fox, J.G., F.E. Dewhirst, J.G. Tully, B.J. Paster, L. Yan, N.S.
Taylor, M.J. Collins, Jr., P.L. Gorelick, and J.M. Ward.
1994. Helicobacter hepaticus sp. nov., a microaerophilic bac-
terium isolated from livers and intestinal mucosal scrapings
from mice. J. Clin. Microbiol. 32:1238–1245.
25. Fox, J.G., L. Yan, B. Shames, J. Campbell, J.C. Murphy, and
X. Li. 1996. Persistent hepatitis and enterocolitis in germfree
mice infected with Helicobacter hepaticus. Infect. Immun. 64:
3673–3681.
26. Ward, J.M., M.R. Anver, D.C. Haines, J.M. Melhorn, P.
Gorelick, L. Yan, and J.G. Fox. 1996. Inflammatory large
bowel disease in immunodeficient mice naturally infected
with Helicobacter hepaticus. Lab. Anim. Sci. 46:15–20.
27. Li, X., J.G. Fox, M.T. Whary, L. Yan, B. Shames, and Z.
Zhao. 1998. SCID/NCr mice naturally infected with Helico-
bacter hepaticus develop progressive hepatitis, proliferative
typhlitis, and colitis. Infect. Immun. 66:5477–5484.
28. Beckwith, C.S., D.J. McGee, H.L. Mobley, and L.K. Riley.
2001. Cloning, expression, and catalytic activity of Helico-
bacter hepaticus urease. Infect. Immun. 69:5914–5920.
29. Ge, Z., D.A. White, M.T. Whary, and J.G. Fox. 2001. Fluo-
rogenic PCR-based quantitative detection of a murine
pathogen, Helicobacter hepaticus. J. Clin. Microbiol. 39:
2598–2602.
30. Malmstrom, V., D. Shipton, B. Singh, A. Al-Shamkhani,
M.J. Puklavec, A.N. Barclay, and F. Powrie. 2001. Cd134l
expression on dendritic cells in the mesenteric lymph nodes
drives colitis in t cell-restored scid mice. J. Immunol. 166:
6972–6981.
31. Lagasse, E., and I.L. Weissman. 1996. Flow cytometric iden-
tification of murine neutrophils and monocytes. J. Immunol.
Methods. 197:139–150.
32. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W.
Muller. 1993. Interleukin-10-deficient mice develop chronic
enterocolitis. Cell. 75:263–274.
33. Kullberg, M.C., A.G. Rothfuchs, D. Jankovic, P. Caspar,T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
119 Maloy et al.
T.A. Wynn, P.L. Gorelick, A.W. Cheever, and A. Sher.
2001. Helicobacter hepaticus-induced colitis in interleukin-
10-deficient mice: cytokine requirements for the induction
and maintenance of intestinal inflammation. Infect. Immun.
69:4232–4241.
34. Chin, E.Y., C.A. Dangler, J.G. Fox, and D.B. Schauer. 2000.
Helicobacter hepaticus infection triggers inflammatory bowel
disease in T cell receptor alphabeta mutant mice. Comp. Med.
50:586–594.
35. Burich, A., R. Hershberg, K. Waggie, W. Zeng, T. Brabb,
G. Westrich, J.L. Viney, and L. Maggio-Price. 2001. Helico-
bacter-induced inflammatory bowel disease in IL-10- and T
cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol.
281:G764–G778.
36. Shevach, E.M. 2002. CD4  CD25  suppressor T cells: more
questions than answers. Nat. Rev. Immunol. 2:389–400.
37. Stockinger, G., T. Barthlott, and G. Kassiotis. 2001. T cell
regulation: a special job or everyone’s responsibility? Nat. Im-
munol. 2:757–758.
38. Hori, S., T.L. Carvalho, and J. Demengeot. 2002.
CD25 CD4  regulatory T cells suppress CD4  T cell-medi-
ated pulmonary hyperinflammation driven by Pneumocystis
carinii in immunodeficient mice. Eur. J. Immunol. 32:1282–
1291.
39. von Freeden-Jeffry, U., N. Davidson, R. Wiler, M. Fort, S.
Burdach, and R. Murray. 1998. IL-7 deficiency prevents de-
velopment of a non-T cell non-B cell-mediated colitis. J. Im-
munol. 161:5673–5680.
40. Takeda, K., B.E. Clausen, T. Kaisho, T. Tsujimura, N.
Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity
and development of chronic enterocolitis in mice devoid of
Stat3 in macrophages and neutrophils. Immunity. 10:39–49.
41. Young, V.B., C.A. Dangler, J.G. Fox, and D.B. Schauer.
2000. Chronic atrophic gastritis in SCID mice experimentally
infected with Campylobacter fetus. Infect. Immun. 68:2110–
2118.
42. Vallance, B.A., W. Deng, L.A. Knodler, and B.B. Finlay.
2002. Mice lacking T and B lymphocytes develop transient
colitis and crypt hyperplasia yet suffer impaired bacterial
clearance during Citrobacter rodentium infection. Infect. Immun.
70:2070–2081.
43. Kullberg, M.C., D. Jankovic, P.L. Gorelick, P. Caspar, J.J.
Letterio, A.W. Cheever, and A. Sher. 2002. Bacteria-trig-
gered CD4  T regulatory cells suppress Helicobacter hepaticus-
induced colitis. J. Exp. Med. 196:505–515.
44. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet,
L.A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie.
2001. Control of intestinal inflammation by regulatory T
cells. Immunol. Rev. 182:190–200.
45. Olivares-Villagomez, D., A.K. Wensky, Y. Wang, and J.J.
Lafaille. 2000. Repertoire requirements of CD4  T cells that
prevent spontaneous autoimmune encephalomyelitis. J. Im-
munol. 164:5499–5507.
46. Stephens, L.A., and D. Mason. 2000. CD25 is a marker for
CD4  thymocytes that prevent autoimmune diabetes in rats,
but peripheral T cells with this function are found in both
CD25  and CD25  subpopulations. J. Immunol. 165:3105–
3110.
47. Annacker, O., R. Pimenta-Araujo, O. Burlen-Defranoux,
T.C. Barbosa, A. Cumano, and A. Bandeira. 2001. CD25 
CD4  T cells regulate the expansion of peripheral CD4 T
cells through the production of IL-10. J. Immunol. 166:3008–
3018.
48. Annacker, O., R. Pimenta-Araujo, O. Burlen-Defranoux,
and A. Bandeira. 2001. On the ontogeny and physiology of
regulatory T cells. Immunol. Rev. 182:5–17.